The administration of the non-psychotropic plant constituent cannabidiol (CBD) is associated with a significant reduction in psychotic symptoms in patients with schizophrenia, according to clinical trial data published in the journal Translational Psychiatry.
Categories: Best of the Web, Law & Politics, Marijuana News, Medical Marijuana
Tags: cbd, schizophrenia.
By:
Rob Schmidt. Permalink: 
Shortlink: http://weedi.st/zcHFx
Tags: cbd, schizophrenia.
By:
Rob Schmidt. Permalink: Shortlink: http://weedi.st/zcHFx
Is it illegal? I don't see it listed in the federal drug schedule. There is at least one company (dixiex.com) selling it nation-wide as an extract from legally imported industrial hemp.
A very good question, it looks like Dixie is part of Marijuana Inc, so I'm sure they have their lawyers all over this issue. The way I see it, CBD is a cannabinoid that is part of the cannabis plant. You can find cannabis (aka. Marihuana… yes, with an "H") on Schedule I of the Controlled Substances Act here: http://www.deadiversion.usdoj.gov/schedules/orang…
I'm actually shocked that they can sell this product in non-medical marijuana states. I guess they are claiming to get their oil from hemp rather than marijuana (which is the same thing, just that hemp is bred for less THC content). There must be a loophole in the law that they are working through.
The loophole is industrial hemp, which isn't really a loophole. Just like how sterile hemp seeds, oil and fiber can be imported for various uses, they are importing a whole plant paste that meets the federal requirements for hemp. They apparently have a hemp importing license from the FDA, and as far as I know, the only requirement is a THC content of less than 0.3%. I don't think they restrict or limit CBD or any other cannabinoid.